ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO596

SPECT/CT with Technetium 99m-Methyl Diphosphonate for the Diagnosis of Severe Symptomatic Hypercalcemia After Rhabdomyolysis Induced AKI in 2 Patients with Cirrhosis

Session Information

  • Trainee Case Reports - III
    October 26, 2018 | Location: Exhibit Hall, San Diego Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Trainee Case Reports

  • 902 Fluid and Electrolytes: Clinical

Authors

  • Ramirez, Silvia, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
  • Gómez Ruiz, Ismael Antonio, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
  • Cohen-Bucay, Abraham, Boston University Medical Center, Boston, Massachusetts, United States
  • Correa-Rotter, Ricardo, Institutor Nacional de la Nutricion, Mexico City, Mexico
Introduction

Rhabdomyolysis induced acute kidney injury (RI-AKI) is often complicated by multiple electrolyte abnormalities. Hypercalcemia (HC) due to soft tissue mobilization of calcium deposits in the recovery phase of RI-AKI has been described yet severe HC is rare. We present two patients with cirrhosis who developed RI-AKI and severe HC, both with SPECT/CT deposit images

Case Description

Case 1: 56-yr-old female, primary biliary cholangitis Child-Pugh B cirrhosis who developed exertional RI-AKI that required hemodialysis (HD). She was hypocalcemic during the oliguric phase; during the recovery phase developed severe HC (peak of 16.2 mg/dl) with neurological symptoms. She required intermittent 13 sessions of HD in addition to volume replacement, diphosphonates, and diuretics and recovered in 8 weeks. Plasma levels of 25-OH and 1-25(OH)2 vitamin D were low, iPTH appropriately suppressed. A SPECT/CT with 99Tcm-methyl diphosphonate (99Tcm-MDP) demonstrated extensive soft tissue tracer accumulation (Fig1). Case 2: 65-yr-old female, Child-Pugh B cirrhosis secondary to hepatitis C, who developed exertional RI-AKI that required HD. Normocalcemic during the oliguric phase yet during the recovery phase developed severe symptomatic HC (peak 14.7 mg/dl), requiring 3 intermittent HD sessions. HC lasted for 2 weeks. Plasma levels of 25-OH and 1-25(OH) vitamin D were low, iPTH level appropriately suppressed and a SPECT/CT with 99Tcm-MDP demonstrated soft tissue tracer accumulation. The evolution of serum calcium, phosphorus, and creatinine levels are showed in Fig1. Both patients had full renal and neurological recovery.

Discussion

SPECT/CT with 99Tcm-MDP is a useful tool to identify soft tissue calcium deposits in patients with HC after RI-AKI. Intermittent HD is an effective treatment for severe HC. Since both of our patients were cirrhotic, we postulate that cirrhosis might be a risk factor for HC during the recovery phase of RI-AKI.